Literature DB >> 2301852

Extrapulmonary tuberculosis in the United States.

H L Rieder1, D E Snider, G M Cauthen.   

Abstract

From 1963 to 1986, the number of reported cases of pulmonary tuberculosis in the United States declined an average of 5.0% annually, and the number of cases of extrapulmonary tuberculosis declined an average of 0.9% annually over the same period. In 1986, 17.5% of all cases of tuberculosis were extrapulmonary. Of pulmonary cases, 63.0% occurred among racial ethnic minorities and the foreign-born, whereas of extrapulmonary cases, the respective proportion was 71.2%. After adjustment for other variables, the proportion of extrapulmonary tuberculosis among all patients with tuberculosis by age was found to be largest in children and generally to decrease with increasing age, larger among black, Asian, and American Indian than among non-Hispanic white patients, larger among female than among male patients, and larger among the foreign-born than among patients born in the United States. The smaller decline in extrapulmonary tuberculosis over the years may be partially due to changes in the demographic characteristics of patients with tuberculosis. Considerable differences in susceptibility to different sites of extrapulmonary tuberculosis by age, race/ethnicity, sex, and country of origin were found. The reasons for these differences remain largely unexplained.

Entities:  

Mesh:

Year:  1990        PMID: 2301852     DOI: 10.1164/ajrccm/141.2.347

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  75 in total

Review 1.  Tuberculosis: 6. Extrapulmonary disease.

Authors:  A Fanning
Journal:  CMAJ       Date:  1999-06-01       Impact factor: 8.262

2.  Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model.

Authors:  Philana Ling Lin; Amy Myers; Le'Kneitah Smith; Carolyn Bigbee; Matthew Bigbee; Carl Fuhrman; Heather Grieser; Ion Chiosea; Nikolai N Voitenek; Saverio V Capuano; Edwin Klein; JoAnne L Flynn
Journal:  Arthritis Rheum       Date:  2010-02

3.  Tuberculosis among Africans living in the United States, 2000-2009.

Authors:  Bisrat K Abraham; Carla A Winston; Elvin Magee; Roque Miramontes
Journal:  J Immigr Minor Health       Date:  2013-04

4.  Effect of sex, age, and race on the clinical presentation of tuberculosis: a 15-year population-based study.

Authors:  Xinyu Zhang; Aase B Andersen; Troels Lillebaek; Zaza Kamper-Jørgensen; Vibeke Østergaard Thomsen; Karin Ladefoged; Carl F Marrs; Lixin Zhang; Zhenhua Yang
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

5.  Mortality associated with central nervous system tuberculosis.

Authors:  Hana M El Sahly; Larry D Teeter; Xi Pan; James M Musser; Edward A Graviss
Journal:  J Infect       Date:  2007-10-17       Impact factor: 6.072

6.  Tuberculosis in indigenous peoples in the U.S., 2003-2008.

Authors:  Emily Bloss; Timothy H Holtz; John Jereb; John T Redd; Laura Jean Podewils; James E Cheek; Eugene McCray
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

7.  A case of fatal septicemia due to Mycobacterium kansasii.

Authors:  J Kaustová; A Martínek; R Curík
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

8.  The role of tissue plasminogen activator use and systemic hypercoagulability in central line-associated bloodstream infections.

Authors:  Kinna Thakarar; Matthew Collins; Lana Kwong; Carol Sulis; Cathy Korn; Nahid Bhadelia
Journal:  Am J Infect Control       Date:  2014-02-20       Impact factor: 2.918

9.  Application of optical imaging to study of extrapulmonary spread by tuberculosis.

Authors:  Ying Kong; Selvakumar Subbian; Suat L G Cirillo; Jeffrey D Cirillo
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

10.  Risk factors for mortality among patients with extrapulmonary tuberculosis at an academic inner-city hospital in the US.

Authors:  Ekaterina V Kourbatova; Michael K Leonard; Javier Romero; Colleen Kraft; Carlos del Rio; Henry M Blumberg
Journal:  Eur J Epidemiol       Date:  2006-10-27       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.